Business Description
ProMIS Neurosciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA74346M1095
Description
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -1.62 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4.4 | |||||
| 3-Year EPS without NRI Growth Rate | -6.6 | |||||
| 3-Year FCF Growth Rate | -6.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.81 | |||||
| 9-Day RSI | 37.51 | |||||
| 14-Day RSI | 39.18 | |||||
| 6-1 Month Momentum % | -41.62 | |||||
| 12-1 Month Momentum % | -76.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.44 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -57.6 | |||||
| Shareholder Yield % | -0.51 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -160.73 | |||||
| ROIC % | -103654.05 | |||||
| ROCE % | -1427.5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.99 | |||||
| EV-to-EBITDA | -2.99 | |||||
| EV-to-FCF | -2.01 | |||||
| Earnings Yield (Greenblatt) % | -33.47 | |||||
| FCF Yield % | -48.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ProMIS Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.648 | ||
| Beta | -0.05 | ||
| Volatility % | 108.39 | ||
| 14-Day RSI | 39.18 | ||
| 14-Day ATR (€) | 0.046756 | ||
| 20-Day SMA (€) | 1.0405 | ||
| 12-1 Month Momentum % | -76.4 | ||
| 52-Week Range (€) | 0.865 - 4.28 | ||
| Shares Outstanding (Mil) | 29.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ProMIS Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ProMIS Neurosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ProMIS Neurosciences Inc Frequently Asked Questions
What is ProMIS Neurosciences Inc(FRA:23J0)'s stock price today?
The current price of FRA:23J0 is €0.94. The 52 week high of FRA:23J0 is €4.28 and 52 week low is €0.87.
When is next earnings date of ProMIS Neurosciences Inc(FRA:23J0)?
The next earnings date of ProMIS Neurosciences Inc(FRA:23J0) is 2024-11-14 Est..
Does ProMIS Neurosciences Inc(FRA:23J0) pay dividends? If so, how much?
ProMIS Neurosciences Inc(FRA:23J0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers